Earable Neuroscience, Excelpoint Ink Partnership to Accelerate the Commercialisation of FRENZ Brainband
March 31, 2023 | ACN NewswireEstimated reading time: 3 minutes
Earable Neuroscience U.S., is pleased to announce a strategic partnership with Singapore-based Excelpoint Technology Pte. Ltd., to accelerate the commercialisation of the world's first AI-powered consumer wearable, FRENZ Brainband, which tracks and stimulates brain activities to enhance mental well-being through improvements in sleep, relaxation and focus.
FRENZ™ Brainband can precisely tracks vital data points in real-time, provides instant personalized feedback with cognitive behavioral therapy content via the integrated bone-conduction speakers, and leverages AI and machine learning algorithms to continuously evolve and provide meaningful insights to enhance mental well-being for individuals.
Since the COVID-19 pandemic began, researchers around the world have documented a surge in sleep disorders which affect overall health, safety and quality of life.
Powered by proprietary technologies, FRENZ™ Brainband is an invention of Earable® Neuroscience, founded by Dr Tam Vu, a scientist and professor with lifelong research in neuroscience and computer science, is a deep tech company focused on delivering scalable, human-centric neuroscience solutions that improve the everyday experience — from deep sleep to all-day focus.
With eight years of intensive deep tech R&D by scientists from the University of Colorado Boulder and University of Oxford, FRENZ™ Brainband holds 15 global patents in machine learning algorithms, materials science, and electrical engineering. FRENZ™ Brainband has been accorded multiple awards in various international technology and design competitions, marking its position as the world's first AI-powered consumer head wearable dedicated for improving quality of sleep and cognitive functions.
Singapore-based Excelpoint was established in 1987 and it has grown into a leading regional electronics components distributor providing quality electronic components from leading electronics group such as ADI, Xilinx, NXP, Samsung, Qualcomm, Panasonic, Fujitsu, TDK, and Epson, among others as well as engineering design services and supply chain management to original equipment manufacturers ("OEMs"), ODMs and electronics manufacturing services ("EMS") in the Asia Pacific region. Excelpoint is also the authorised distributor of Qualcomm in ASEAN, India, Australia and New Zealand.
Strategic Partnership of Earable® Neuroscience and Excelpoint to Accelerate the Commercialisation of FRENZ™ Brainband
Combined with its neuroscience data platform, Earable® Neuroscience is at the final stage of commercialisingFRENZ™ Brainband.
The main goal of the strategic partnership between Earable® Neuroscience and Excelpoint is for both companies to leverage on each other's capabilities and networks to accelerate the commericalisation of FRENZ™ Brainband, thereby enabling an entirely new world of possibilities for neuroscience applications.
As part of the strategic partnership, Excelpoint will be the exclusive procurement partner for the electronics components used for the production of FRENZ™ Brainband. In addition, Excelpoint will provide favorable procurement terms to support Earable® Neuroscience so as to accelerate the commercialisation phase of FRENZ™ Brainband.
At the same time, PlanetSpark Pte. Ltd., ("PlanetSpark") the entrepreneurial and strategic investment arm of Excelpoint, is currently exploring its options to make an investment in Earable® Neuroscience.
Commenting on the strategic partnership, Dr. Tam Vu, Founder and CEO of Earable® Neuroscience, said: "Earable® Neuroscience's vision is to make the daily benefits of neuroscience accessible to billions of people to enhance their cognitive functions and unlock the brain's potential, improving productivity, mental wellbeing, and quality of life.
Excelpoint's global expertise and ecosystem in electronic components and supply chain management makes them the ideal partner to help us to secure the scalability of this vision."
Mr. Albert Phuay, Chairman of Excelpoint added, "We share Earable® Neuroscience aspirations to drive innovation in the field of disruptive sleeptech and we are thrilled with this partnership to accelerate the commercialisation of FRENZ™ Brainband to new levels of growth and expansion.
We believe that Earable®'s advanced neuroscience expertise, combined with our ecosystem will enable us to scale up the production of high-quality and cutting-edge sleeptech products that make a meaningful impact in the lives of people around the world."
Suggested Items
iNEMI Names Grace O'Malley CTO
05/02/2024 | iNEMIThe Board of Directors of the International Electronics Manufacturing Initiative (iNEMI) has named Grace O'Malley Chief Technical Officer (CTO).
ZESTRON Academy Launches 2024 Advanced Packaging & Power Electronics Webinar Series
05/01/2024 | ZESTRONZESTRON, the leading global provider of high-precision cleaning products, services, and training solutions in the electronics manufacturing and semiconductor industries, proudly announces the launch of its highly anticipated webinar series on Advanced Packaging & Power Electronics, a webinar series on the latest innovations, cleaning, and corrosion challenges.
NextFlex Convenes the Hybrid Electronics Community at Binghamton University
05/01/2024 | NextFlexBinghamton University hosted the NextFlex hybrid electronics community on April 18 for a day of expert presentations, breakout sessions on technology and manufacturing topics, and networking.
HQ NextPCB of HQ Electronics Debut on the International Stage for Electronics Manufacture at IPC APEX 2024
05/01/2024 | PRNewswireHQ NextPCB of HQ Electronics, a leading Chinese-based multilayer PCB manufacturer and assembly house showcased its industrial prowess on the international stage for the first time at the IPC APEX Expo 2024.
GPV’s Q1 2024 Interim Financial Report Shows Strong Navigation in Uncertain Times
05/01/2024 | GPVDanish-based GPV recorded an expected drop in sales to DKK 2.3 billion for the first quarter of 2024. The decline also affected the operating profit, which was DKK 155 million compared to DKK 179 million in the same quarter last year, although the EBITDA margin was maintained. In general, demand has been softer in 2024, but GPV continues to invest for the long-term and expects the trend to turn in the second half of 2024.